Reuters logo
BRIEF-Sun Pharmaceutical Industries announces manufacturing tie-up with Samsung Biologics
July 4, 2017 / 2:53 AM / 3 months ago

BRIEF-Sun Pharmaceutical Industries announces manufacturing tie-up with Samsung Biologics

July 4 (Reuters) - Sun Pharmaceutical Industries Ltd :

* Strategic manufacturing tie-up with Samsung Biologics for Tildrakizumab

* Unit, Samsung Biologics to manufacture Tildrakizumab

* Drug is an investigational IL-23p19 inhibitor being evaluated for the treatment of moderate to severe plaque psoriasis

* Approximate value of the contract will be US$ 55.5 million

Source text - bit.ly/2sGXpNR

Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below